Microalbuminuria, decreased fibrinolysis, and inflammation as early signs of atherosclerosis in long-term survivors of disseminated testicular cancer-Reference-Cited by-同舟云学术

Microalbuminuria, decreased fibrinolysis, and inflammation as early signs of atherosclerosis in long-term survivors of disseminated testicular cancer

Published:2004-03 Issue:5 Volume:40 Page:701-706
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Nuver J.,Smit A.J.,Sleijfer D.Th.,van Gessel A.I.,van Roon A.M.,van der Meer J.,van den Berg M.P.,Burgerhof J.G.M.,Hoekstra H.J.,Sluiter W.J.,Gietema J.A.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference23 articles.

1. Long-term follow-up of cardiovascular risk factors in patients given chemotherapy for disseminated nonseminomatous testicular cancer;Gietema;Ann. Intern. Med.,1992

2. Evaluation of long-term toxicity after chemotherapy for testicular cancer;Bokemeyer;J. Clin. Oncol.,1996

3. Excessive annual BMI increase after chemotherapy among young survivors of testicular cancer;Nord;Br. J. Cancer,2003

4. Cardiovascular morbidity in long-term survivors of metastatic testicular cancer;Meinardi;J. Clin. Oncol.,2000

5. Cardiovascular disease as a long-term complication of treatment for testicular cancer;Huddart;J. Clin. Oncol.,2003

Cited by 127 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of myocardial injury with adverse long-term survival among cancer patients;European Journal of Preventive Cardiology;2024-03-21

2. Effect of chemotherapy in tumor on coronary arteries: Mechanisms and management;Life Sciences;2024-02

3. Irbesartan ameliorates inflammation via transendothelial leukocyte migration due to VCAM-1/NOX-1 signaling in;IRAN J BASIC MED SCI;2023

4. Cardiotoxicity of Chemotherapy in Lynch Syndrome – A Literature Review;Romanian Journal of Military Medicine;2023-10-01

5. Revisiting treatment-related cardiotoxicity in patients with malignant lymphoma—a review and prospects for the future;Frontiers in Cardiovascular Medicine;2023-08-30